Research paper
 
CC-BY-NC 4.0
 
 

Acute effects of short term use of e-cigarettes on airways physiology and respiratory symptoms in smokers with and without airways obstructive diseases and in healthy non smokers

Sofia Vakali 1,  
 
1
1rst Respiratory Medicine Department, “Sotiria” General Hospital of Chest Diseases, National and Kapodistrian University of Athens
2
1rst ICU, “Evaggelismos” General Hospital, National and Kapodistrian University of Athens.
Tob. Prev. Cessation 2017;3(March):5
Publish date: 2017-03-01
Submission date: 2016-07-12
Final revision date: 2016-10-31
Acceptance date: 2016-12-15
KEYWORDS:
TOPICS:
 
ABSTRACT:
Introduction:
Although the use of e-cigarettes is increasing worldwide, their short and long-term effects remain undefined. We aimed to study the acute effect of short-term use of e-cigarettes containing nicotine on lung function and respiratory symptoms in smokers with airways obstructive disease (COPD, asthma), “healthy” smokers, and healthy never smokers.

Methods:
Respiratory symptoms, vital signs, exhaled NO, airways temperature, and airways resistance (Raw), specific airway conductance (sGaw) and single nitrogen breath test were assessed before and immediately after short term use of an e-cigarette containing 11 mg of nicotine in COPD, asthma, ‘’healthy” smokers, and never-smokers. The effect of nicotine-free e-cigarettes in healthy never smokers was also studied.

Results:
Acute cough was reported by the majority of participants. Short-term use of nicotine e-cigarettes was associated: a) with increased heart rate in all subjects except COPD, b) decreased oxygen saturation in “healthy” and COPD smokers, c) increased Raw in asthmatic, “healthy” smokers, and healthy never smokers, d) decreased sGaw in healthy subjects, and e) changed slope of phase III curve in asthmatic smokers. Short-term use of nicotine-free e-cigarette increased Raw, decreased sGaw and created a pleasant feeling.

Conclusions:
Short term use of e-cigarette has acute effects on airways physiology and respiratory symptoms in COPD smokers, asthmatic smokers, “healthy” smokers and healthy never smokers. E-cigarette use is associated with health effects in healthy never smokers irrespectively of nicotine concentration. More studies are needed to investigate both short and long term effects of e-cig.

CORRESPONDING AUTHOR:
Paraskevi A. Katsaounou   
1rst ICU Clinic, “Evaggelismos” General Hospital, National and Kapodistrian University of Athens, 45-7 Ipsilandou str, 10676 Athens,Greece
 
REFERENCES:
1. Vardavas CI, Filippidis FT, Agaku IT. Determinants and prevalence of e-cigarette use throughout the European Union: a secondary analysis of 26 566 youth and adults from 27 Countries. Tob Control 2015 Sep; 24(5):442-8. doi: 10.1136/tobaccocontrol-2013-051394. Epub 2014 Jun 16.
2. Filippidis FT, Laverty AA, Gerovasili V, Vardavas CI. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob Control. 2016 May 24. doi: 10.1136/tobaccocontrol-2015-052771.
3. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016. doi: 10.1016/S2213-2600(15)00521-4.
4. Scheffler S, Dieken H, Krischenowski O, Förster C, Branscheid D, Aufderheide M.Evaluation of E-cigarette Liquide vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health. 2015 Apr 8;12(4):3915-25. doi: 10.3390/ijerph120403915.
5. Scheffler S, Dieken H, Krischenowski O, Aufderheide M.Cytotoxic Evaluation of e-Liquid Aerosol using Different Lung-Derived Cell Models. Int J Environ Res Public Health. 2015 Oct 5;12(10):12466-74. doi: 10.3390/ijerph121012466.
6. Wu Q, Jiang D, Minor M, Chu HW. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One. 2014 Sep 22; 9(9). doi: 10.1371/journal.pone.0108342.
7. Vicky Yu, Mehran Rahimy, Avinaash Korrapati, Yinan Xuan, Angela E Zou, Aswini R Krishnan, Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral oncology (2016). doi: 10.1016/j.oraloncology.2015.10.018.
8. Sancilio S, Gallorini M, Cataldi A, di Giacomo V. Cytotoxicity and apoptosis induction by e-cigarette fluids in human gingival fibroblasts. Clin Oral Investig. 2016;20:477–483. doi: 10.1007/s00784-015-1537-x
9. Rubenstein DA, Hom S, Ghebrehiwet B, Yin W. Tobacco and e-cigarette products initiate Kupffer cell inflammatory responses. Mol Immunol. 2015 Oct; 67(2 Pt B):652-60. doi: 10.1016/j.molimm.2015.05.020.
10. Schweitzer KS, Chen SX, Law S, Van Demark M, Poirier C, Justice MJ, Hubbard WC, Kim ES, Lai X, Wang M, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol. 2015;309:L175–187. doi: 10.1152/ajplung.00411.2014.
11. Yoshiyama S, Chen Z, Okagaki T, Kohama K, Nasu-Kawaharada R, Izumi T, Ohshima N, Nagai T, Nakamura A. Nicotine exposure alters human vascular smooth muscle cell phenotype from a contractile to a synthetic type. Atherosclerosis. 2014; 237:464–470. doi: 10.1016/j.atherosclerosis.2014.10.019.
12. Sussan TE, Gajghate S, Thimmulappa RK, Ma J, Kim JH, Sudini K, Consolini N1, Cormier SA, Lomnicki S, Hasan F, Pekosz A, Biswal S.Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One.2015 Feb 4; 10(2):e0116861. doi: 10.1371/journal.pone.0116861.
13. Lim HB, Kim SH. Inhallation of e-Cigarette Cartridge Solution Aggravates Allergen-induced Airway Inflammation and Hyper-responsiveness in Mice. Toxicol Res. 2014 Mar; 30(1):13-8. doi: 10.5487/TR.2014.30.1.013.
14. Thota D, Latham E. Case report of electronic cigarettes possibly associated with eosinophilic pneumonitis in a previously healthy active-duty sailor. J Emerg Med. 2014 Jul; 47(1):15-7. doi: 10.1016/j.jemermed.2013.09.034.
15. Hureaux J, Drouet M, Urban. A case report of subacute bronchial toxicity induced by an electronic cigarette. Thorax. 2014 Jun; 69(6):596-7. doi: 10.1136/thoraxjnl-2013-204767.
16. Ioakeimidis N, Vlachopoulos C, Tousoulis D. Efficacy and Safety of Electronic Cigarettes for Smoking Cessation: A Critical Approach. Hellenic J Cardiol. 2016 Jan-Feb; 57(1):1-6. doi: 10.1016/S1109-9666(16)30011-2.
17. Cooke WH, Pokhrel A, Dowling C, Fogt DL, Rickards CA. Acute inhalation of vaporized nicotine increases arterial pressure in young non-smokers: a pilot study. Clin Auton Res. 2015 Aug; 25(4):267-70. doi: 10.1007/s10286-015-0304-z. Epub 2015 Aug 12.
18. Kougias M, Vardavas CI, Anagnostopoulos N, Matsunaga Y, Tzwrtzi A, Lymberi M, Connolly GN, Behrakis PK. The acute effect of cigarette smoking on the respiratory function and FENO production among young smokers. Exp Lung Res. 2013 Oct; 39(8):359-64. doi: 10.3109/01902148.2013.830654.
19. Higenbottam T, Hamilton D, Feyerband C, Clark TJ Acute effects of smoking a single cigarette on the airway resistance and the maximal and partial forced expiratory flow volume curves. Br J Dis Chest.1980 Jan; 74(1):37-46. PMID: 7356912.
  Pubmed
20. McDermott M, Collins MM. Acute effects of smoking on lung airways resistance in normal and bronchitic subjects. Thorax 1965; 20:562-9. PMID: 5862755.
  Pubmed
21. Suzuki S, Sasaki H, Takishima T. Effects of smoking on dynamic compliance and respiratory resistance. Arch Environ Health. 1983 May-Jun; 38(3):133-7. PMID: 6870350.
  Pubmed
22. Costello JF, Sudlow MF, Douglas NJ, Flenley DC. Acute effects of smoking tobacco and a tobacco substitute on lung function in man. Lancet.1975 Oct 11; 2 (7937):678-81. PMID: 52052.
  Pubmed
23. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012 Jun; 141(6):1400-6. doi: 10.1378/chest.11-2443. Epub 2011 Dec 22.
24. Marini S, Buonanno G, Stabile L, Ficco G. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol. 2014 Jul 1;278(1):9-15. doi: 10.1016/j.taap.2014.04.004.
25. Wolfgang Schober, Katalin Szendrei, Wolfgang Matzen, Helga Osiander-Fuchs,Dieter Heitmann, Thomas Schettgen, Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. International journal of hygiene and environmental health 2014 Jul; 217(6):628-37. doi: 10.1016/j.ijheh.2013.11.003. Epub 2013 Dec 6.
26. Polosa R1, Morjaria J2, Caponnetto P3, Caruso M4, Strano S5, Battaglia E6, Russo 7 Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health. 2014 May 8; 11(5):4965-77. doi: 10.3390/ijerph110504965.
27. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005 Apr 15;171(8):912-30. doi: 10.1164/rccm.200406-710ST.
28. Quanjer PhH. Standardized lung function testing. Report Working Party “Standardization of Lung Function Tests”, European Community for Coal and Steel. Eur Respir J 1993; 6 (Suppl. 16): 1–100.
29. Dubois AB, Bothello SJ, Comroe JH Jr. A new method of measuring airway resistance in man using a body plethysmograph. Values in normal subjects and in patients with respiratory disease. J Clin Invest 1956; 35: 327-335. doi: 10.1172/JCI103282.
30. Anthonisen NR, Danson J, Robertson PC, Ross WR. Airway closure as a function of age. Resp Physiol 1970; 8: 58-65.
31. Buist AS, Ross BB. Predicted value for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis 1979; 107: 744-751. doi: 10.1164/arrd.1973.107.5.744
32. Gennimata SA, Palamidas A, Karakontaki F, Kosmas EN, Koutsoukou A, Loukides S, Koulouris NG. Pathophysiology of evolution of small airways disease to overt COPD. COPD. 2010 Aug;7(4):269-75. doi: 10.3109/15412555.2010.497515.
33. Sherwood CL, Boitano S Airway epithelial cell exposure to distinct e-cigarette liquid flavorings reveals toxicity thresholds and activation of CFTR by the chocolate flavoring 2,5-dimethypyrazine. Respir Res. 2016 May 17; 17(1):57. doi: 10.1186/s12931-016-0369-9.
34. Lerner CA, Sundar IK, Yao H, Gerloff J, Ossip DJ, McIntosh S, Robinson R, Rahman I. Vapors produced by electronic cigarettes and e- juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One. 2015 Feb 6;10 (2). doi: 10.1371/journal.pone.0116732. eCollection 2015.
35. Constantinos G., Bibli S, Pavlidou A,Katsaounou P, Kalomenidis I, Zakynthinos S, Papapetropoulos A. Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice. International Congress 2015 – Emerging data on e-cigarettes and their health hazards.
36. Carl D. D’Ruiz, Donald W. Graff, X. Sherwin Yan. Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes. BMC Public Health. 2015; 15: 991. doi: 10.1186/s12889-015-2349-2.
37. Dicpinigaitis PV, Lee Chang A, Dicpinigaitis AJ, Negassa A Effect of e-Cigarette Use on Cough Reflex Sensitivity. Chest. 2016 Jan;149(1):161-5. doi: 10.1378/chest.15-0817.
38. Dicpinigaitis PV, Lee Chang A, Dicpinigaitis AJ, Negassa A. Effect of Electronic Cigarette Use on the Urge-to-Cough Sensation. Nicotine Tob Res. 2016 Aug;18(8):1763-5 doi:10.1093/ntr/ntw021.
39. McNeill A, Brose LS, Calder R, et al. E-cigarettes: an evidence update: a report commissioned by Public Health England. Public Health England, 2015.
40. Pisinger C.Why public health people are more worried than excited over e-cigarettes. BMC Med. 2014 Dec 9;12: 226. doi: 10.1186/s12916-014-0226-y.
41. Green SH, Bayer R, Fairchild AL Evidence, Policy, and E-Cigarettes--Will England Reframe the Debate? N Engl J Med. 2016 Apr 7;374(14):1301-3. doi:10.1056/NEJMp1601154.
42. McKee M, Capewell S. Evidence about electronic cigarettes: a foundation built on rock or sand? BMJ 2015; 351: h4863. doi: 10.1056/NEJMp1601154.
43. E-cigarettes: Public Health England's evidence-based confusion. Editorial. Lancet 2015 Aug 29; 386(9996):829. doi: 10.1016/S0140-6736(15)00042-2.
44. Lundbäck B, Katsaounou P, Lötvall J. The up-rise in e-cigarette use - friend or foe? Respir Res. 2016 May 17; 17(1):52. doi: 10.1186/s12931-016-0371-2.
45. Bell K, Keane H. All gates lead to smoking: the 'gateway theory', e-cigarettes and the remaking of nicotine. Soc Sci Med. 2014 Oct; 119: 45-52. doi: 10.1016/j.socscimed.2014.08.016. Epub 2014 Aug 15.
eISSN:2459-3087